Upgrades
- For Cardinal Health Inc CAH, UBS upgraded the stock from Neutral to Buy. Cardinal Health earned $1.62 in the third quarter, compared to $1.59 in the year-ago quarter. The stock has a 52-week-high of $60.69 and a 52-week-low of $39.05. Cardinal Health's stock last closed at $47.30 per share.
- B of A Securities upgraded the stock for Jabil Inc JBL from Neutral to Buy. In the second quarter, Jabil showed an EPS of $0.50, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $44.20 and a 52-week-low of $17.63. Jabil's stock last closed at $26.76 per share.
- UBS upgraded the stock for McKesson Corp MCK from Neutral to Buy. For the third quarter, McKesson had an EPS of $3.81, compared to year-ago quarter EPS of $3.40. The stock has a 52-week-high of $172.18 and a 52-week-low of $112.60. McKesson's stock last closed at $129.44 per share.
- Wedbush changed the rating for Mr. Cooper Group Inc COOP from Neutral to Outperform. For the first quarter, Mr. Cooper Group had an EPS of ($1.84), compared to year-ago quarter EPS of $4.95. The stock has a 52-week-high of $14.68 and a 52-week-low of $4.31. Mr. Cooper Group's stock last closed at $8.41 per share.
- Raymond James upgraded the stock for Omega Healthcare Investors Inc OHI from Outperform to Strong Buy. Omega Healthcare earned $0.79 in the first quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $45.22 and a 52-week-low of $13.33. Omega Healthcare's stock last closed at $26.11 per share.
- Guggenheim changed the rating for Allogene Therapeutics Inc ALLO from Neutral to Buy. Allogene Therapeutics earned ($0.50) in the first quarter, compared to ($0.32) in the year-ago quarter. The stock has a 52-week-high of $42.99 and a 52-week-low of $17.43. Allogene Therapeutics's stock last closed at $42.12 per share.
- For Aurora Cannabis Inc ACB, Piper Sandler upgraded the stock from Underweight to Neutral. Interestingly, in the third quarter, Aurora Cannabis's EPS was ($1.02). The stock has a 52-week-high of $9.05 and a 52-week-low of $0.60. Aurora Cannabis's stock last closed at $6.61 per share.
Downgrades
- For Canada Goose Holdings Inc GOOS, B of A Securities downgraded the stock from Neutral to Underperform. Canada Goose Holdings earned $0.83 in the third quarter, compared to $0.72 in the year-ago quarter. The stock has a 52-week-high of $51.70 and a 52-week-low of $12.94. Canada Goose Holdings's stock last closed at $20.69 per share.
- For U.S. Well Services Inc USWS, Piper Sandler downgraded the stock from Overweight to Neutral. In the first quarter, U.S. Well Services earned ($0.51). The stock has a 52-week-high of $7.98 and a 52-week-low of $0.25. U.S. Well Services's stock last closed at $0.43 per share.
- For Wayfair Inc W, Citigroup downgraded the stock from Neutral to Sell. Wayfair earned ($2.30) in the first quarter, compared to ($1.62) in the year-ago quarter. The stock has a 52-week-high of $197.06 and a 52-week-low of $21.70. Wayfair's stock last closed at $172.89 per share.
- Benchmark downgraded the stock for CynergisTek Inc CTEK from Buy to Hold. In the first quarter, CynergisTek showed an EPS of ($0.17), compared to ($0.09) from the year-ago quarter. The stock has a 52-week-high of $4.94 and a 52-week-low of $1.11. CynergisTek's stock last closed at $1.96 per share.
Initiations
- Citigroup initiated coverage on Dropbox Inc DBX with a Buy rating. The price target for Dropbox is set at $27.00. In the first quarter, Dropbox showed an EPS of $0.17, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $26.20 and a 52-week-low of $14.55. Dropbox's stock last closed at $21.50 per share.
- Citigroup initiated coverage on Smartsheet Inc SMAR with a Neutral rating. The price target for Smartsheet is set at $58.00. Smartsheet earned ($0.13) in the fourth quarter, compared to ($0.07) in the year-ago quarter. The stock has a 52-week-high of $57.88 and a 52-week-low of $30.91. Smartsheet's stock last closed at $52.08 per share.
- With a rating of Buy, Citigroup initiated coverage on Atlassian Corporation PLC TEAM. The price target is set at $252.00 for Atlassian Corporation. Atlassian Corporation earned $0.25 in the third quarter, compared to $0.21 in the year-ago quarter. The stock has a 52-week-high of $182.60 and a 52-week-low of $107.00. Atlassian Corporation's stock last closed at $179.79 per share.
- With a rating of Neutral, Citigroup initiated coverage on Zoom Video Communications Inc ZM. The price target is set at $186.00 for Zoom Video Communications. Zoom Video Communications earned $0.15 in the fourth quarter. The stock has a 52-week-high of $181.50 and a 52-week-low of $60.97. Zoom Video Communications's stock last closed at $167.91 per share.
- Guggenheim initiated coverage on Phreesia Inc PHR with a Buy rating. The price target for Phreesia is set at $31.00. Interestingly, in the fourth quarter, Phreesia's EPS was ($0.10). The stock has a 52-week-high of $34.85 and a 52-week-low of $16.01. Phreesia's stock last closed at $25.92 per share.
- With a rating of Buy, Guggenheim initiated coverage on Health Catalyst Inc HCAT. The price target is set at $33.00 for Health Catalyst. Health Catalyst earned ($0.16) in the first quarter. The stock has a 52-week-high of $49.85 and a 52-week-low of $17.48. Health Catalyst's stock last closed at $27.93 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsFinancialsHealth CareHealth Care DistributorsInitiationsThrifts & Mortgage Financetop upgrades
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in